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Introduction
Von Recklinghausen’s disease (VRD), also
known as neurofibromatosis-1 (NF-1) is an auto-
somal-dominant disease that occurs with a preva-
lence of 1:2500-3000, independently from ethny
and gender. Approximately 50% of cases are due
to mutation of chromosome 17. Clinically, NF-1 is
recognised by the presence of numerous “café-au-
lait” skin macules, but 25% of affected patients de-
velop multiple cutaneous and central nervous sys-
tem (CNS) tumors that are histologically charac-
terized as neurofibroma, pheochromocytoma or fi-
brosarcoma [1, 2].
To establish the diagnosis of NF-1, molecular
definition of the disease is not necessary. Clinical
criteria for the diagnosis of NF-1 were defined in
1997 and confirmed in 2007 [3]; two or more of
the following criteria must be met:
– six or more café-au-lait spots >5 mm in diam-
eter before puberty, or >15 mm after puberty;
– two or more typical neurofibromas of any type,
or one plexiform neurofibroma;
– frackles/hyperpigmentation spots in area inac-
cessible to sunlight (axilla, groin);
– two ore more iris hamartomas (Lisch nodules);
– typical bone abnormalities (see below);
– first-degree relative meeting the above criteria.
The thoracic manifestations of NF-1 are most
commonly cutaneous, but they can also be skeletal
and pulmonary [4]. The most common thoracic
skeletal manifestations of NF-1 involve the spine
and ribs. Characteristic deformities of the ribs in-
clude well-marginated erosions of one or more
ribs, and the separation of adjacent ribs due to
plexiform neurofibromas. Spinal abnormalities
can present as kyphoscoliosis, posterior scalloping
of the vertebral bodies and enlargement of neural
foramina [2]. Lung manifestations, that usually in-
clude interstitial lung disease (ILD) and thin-
walled bullae, are reported in as many as 10-20%
of adult patients with NF-1. Although these find-
ings may be incidental, sometimes patients present
with dyspnea that may also result from lung mes-
enchymal abnormalities [5]. Pulmonary fibrosis is
usually bilateral and simmetric, predominantly
basal [6]. Typically, ILD occurs in association with
bullae that are thin-walled, located in the upper
lobes, and usually asymmetric [1, 6].
Case report
A 16-year-old male non-smoker, with ecto-
morph body build, affected by VRD was referred
to our hospital complaining of chest pain and pal-
pitations. His vitals signs and haemoglobin oxygen
saturation were normal. Chest X-ray examination
showed left pneumothorax (fig. 1). The patient
past medical history was unremarkable, except for
the diagnosis of VRD made in 2004. This diagno-
sis was based on physical examination, which re-
vealed multiple (>6) large café-au-lait macules on
the chest skin and in cutaneous areas of the ab-
domen usually not exposed to sunlight (fig. 2).
Other clinical manifestations of VRD (CNS, skele-
tal, neurological) were absent. The pneumothorax
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Lung interstitial diseases and bullae are described as
possible complications of neurofibromatosis type-1 (NF-1),
a genetic disorder inherited as a autosomal-dominant
trait. We report the case of a 16-year-old male non-smok-
er with NF-1, who presented with pneumothorax caused
by ruptured lung bullae. The case of this young patient,
successfully treated by video-assisted thoracoscopic resec-
tion of bullae, supports the concept that pulmonary alter-
ations may be part of the NF-1 syndrome, rather than as
an unrelated complication.
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was treated by tube drainage of the left pleural
space. Since pulmonary air leakage persisted for
several days, high-resolution computed tomogra-
phy (HRCT) of the chest was obtained. Chest
scans revealed bilateral apical lung bullae, with di-
ameter up to 1.5 cm (fig. 3). Surgical treatment of
persistent pneumothorax was decided. With a left
3-port video-thoracoscopic approach, the apical
lung bullae were resected and successful pleurode-
sis was obtained by partial parietal pleurectomy.
Histological examination of the resected pul-
monary bullae revealed emphysematous parenchy-
ma with sub-pleural bullae. The post-operative
course was uneventful and after seven days the pa-
tient was discharged in good condition. At 30-day
follow-up the patient was asymptomatic.
Discussion
NF-1 is a neurogenetic disorder with wide-
spread involvement of neuroectodermal and meso-
dermal tissues [7, 8]. Lung involvement consisting
of ILD and/or bullae is not infrequent in the con-
text of NF-1. The association between NF-1 and
ILD was first reported in 1963 by Davies [9], and
several authors described coexisting lung diseases
in 10-20% of patients with NF-1 [5, 9]. A review
of the pertinent literature revealed many different
types of lung lesions detected by radiological
imaging in VRD patients, as summarized in table
1. Associated pulmonary manifestations most
commonly include bilateral fibrosis with basal pre-
dominance, associated or not with thin-walled bul-
lae that typically occur in the upper lobes [1, 2, 5,
9-16]. Less frequently intra thoracic tumour and
cystic disorders have been described [1, 2, 5].
However, it is uncertain whether the development
of ILD is a peculiar phenotypic manifestation of
NF-1. A recent article questioned such association,
reporting that the evidence supporting a causative
relationship between NF-1 and interstitial diseases
is poor, and suggested that the latter are mainly
smoking-induced manifestations [15]. However,
Zamora et al. proposed that NF-1 in association
with ILD represents a distinct clinical entity [1].
The pathogenesis of ILD in patients with NF-1 is
uncertain. Patchefsky et al. suggested that pul-
monary fibrosis in NF-1 may be determined by in-
creased deposition of collagen in the lung, causing
a fibrotic environment [12]. Fabricant et al. postu-
lated a similar pathogenetic mechanism, attribut-
ing the cause of ILD to myofibroblast activation
by increased nerve growth factor levels in NF-1
patients [17].
In our case, the patient had a pre-existing clin-
ical diagnosis of NF-1, documented by café-au-
lait macules on the chest and lower abdomen skin,
and presented with pneumothorax caused by rup-
tured lung bullae. His chest HRCT showed bilat-
eral apical lung bullae, without signs of fibrosis,
and histology of the resected bullous parenchyma
revealed emphysematous lung. Differently from
previous reports of lung bullous disease associat-
ed with VRD, that occurred after the fourth
decade of life [11, 13, 14, 16], the case here de-
scribed occurred in a non-smoker young male,
and supports the concept that NF-1 with bullous
Fig. 1. Chest X-ray exam on admission, showing left-sided pneu-
mothorax.
Fig. 2. Café-au-lait cutaneous macules on the chest and abdomen.
Fig. 3. High resolution computed tomography scan of the chest, show-
ing pulmonary bullous disease bilaterally, and left-sided pneumothorax.
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lung disease may be a distinct clinical entity, un-
related to smoking [1, 5, 9].
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Table 1. - Chest radiographic findings of lung abnormalities associated with NF-1
Cases of thoracic Radiographic Predominant RespiratoryAuthor abnormalities 
appearance lung site symptomsin VRD* patients
Davies PDB, 1963 [9] 9 Mottled opacities Lower lobe Breathlessnes, dyspnoea
Israel-Asselain R, 1965 [10] 2 Reticular/linear opacities Upper lobe Dyspnoea, coughNodular opacities Lower lobe
Massaro D, 1966 [11] 20 Bullae Upper lobe Not AvailableMottled and linear infiltrate Diffuse
Patchefsky A, 1973 [12] 1 Diffuse interstitial infiltrations Lower lobe Dyspnoea
Volpini E, 1995 [13] 1 Severe bullous emphysema Upper lobe Breathlessnes
Yokoyama A, 1997 [14] 1 Bullae and acinar emphysema Upper lobe No
Rossi SE, 1999 [2] Not Available Thin-walled bullae Upper lobe Not AvailableLung fibrosis Lower lobe
Pulmonary nodules
Ryu JH, 2005 [15] 22 Cystic airspace Not Available Not AvailableBullae
Interstitial infiltrate
Thin-walled bullae Upper lobe
Zamora AC, 2007 [1] 64 Linear opacities Lowe lobe Dyspnoea, cough, chest painBullous emphysema Upper lobe
Thin-walled cyst Upper lobe
Oikonomou A, 2010 [5] 6 Thin-walled cyst Upper lobe No
Zanobetti M, 2012 [16] 1 Small thin-walled cyst Lower lobe Dyspnoea, cough
* VRD = Von Recklinghausen’s disease.
